advertisement
Amylin Pharms initiated with "neutral"
04/28/09 - FTN Midwest
NEW YORK, April 28 (newratings.com) - Analysts at FTN Midwest initiate coverage of Amylin Pharms (AMLN) with a "neutral" rating.
Share Recommend this article to a friend
add AMLN to my stocks and get e-mail alerts on Amylin Pharmaceuticals
News